Nuclear medicine department utilizes radio-isotopes in the diagnosis and treatment of diseases. Nuclear medicine techniques are very safe without significant adverse effects. It is utilized in the evaluation of the function of the organs. Nuclear medicine techniques can identify diseases early in their course, even before conventional imaging methods are able to detect the disease.
Positron emission tomography (PET-CT) is indispensable in evaluation of oncology patients. It is also utilized in evaluation of myocardial viability and in evaluation of neurological conditions.
Gamma Camera : Monday / Wednesay / Friday (9 AM to 5 PM)
PET-CT : Tuesday / Thursday / Saturday (8 AM to 4 PM)
» GE Infinia Hawkeye-4 : Hybrid SPECT/CT gamma camera with 4 slice CT
» GE discovery 600 - BGO crystal full ring PET scanner with 16 slice diagnostic CT
Equipments required for measurement of radiation and radiation safety equipments are also available.
Gamma Camera - All diagnostic nuclear medicine techniques are routinely performed in the department.
Renal studies (DTPA, DMSA, EC, DRCG), Skeletal survey (MDP bone scintigraphy), Myocardial perfusion imaging for myocardial ischemia and viability, Lymphoscintigraphy, Endocrine evaluation (Thyroid, Parathyroid, Adrenal scintigraphy) are routinely performed with prior appointments. Serotonin receptor imaging, GI bleed imaging, Meckels scan and special procedures are available at request.
PET/CT - Amala PET scan is the first PET scan in North Kerala and only the 2nd PET scan in entire Kerala. Oncology PET, Cardiac and neurololgy PET studies, Fluoride PET for skeletal evaluation are done routinely. At present PET-CT scans are performed on alternate days with prior appointment.
Radionuclide therapy - Low dose radioiodine therapy for benign thyroid diseases, bone pain palliation are routinely performed. Imaging, treatment advice and follow up thyroid cancer patients are available.
Outpatient services for thyroid diseases and thyroid cancer are available on all Monday / Wednesday / Friday.
|Date of Birth|
|Dr. Sureshkumar A C||Professor and HOD||DNB (Nuclear medicine), 2014||2 years||-||Profile|
Graduated from K.A.P.V Govt medical college,Trichy; Diploma in Nuclear medicine (DRM, 2010) from Radiation Medicine Center (RMC), Tata Memorial hospital, Mumbai and DNB (Nuclear medicine, 2014) from Apollo Hospitals, Chennai.
Fellow of European board of Nuclear medicine.
Worked at Dr.Kamakshi Memorial Hospital, Chennai as a junior consultant (2010-2012); as registrar in Apollo speciality hospitals, Chennai (2014-2015) and currently working as consultant and In charge at Department of Nuclear medicine and PET/CT, Amala institute of medical sciences (since 2015).
Member of society of Nuclear medicine and Association of nuclear medicine physicians of India.
Attended various national and international conferences and have done oral and poster presentations. Published papers in nationalised journals.
Areas of special interest - Therapeutic Nuclear medicine and Nuclear oncology.
1. Harisankar CB, Mittal BR, Bhattacharya A, Kashyap R, Bhansali A. Iodine-131 meta-iodobezylguanidine single photon emission computed tomography/computerized tomography in diagnosis of neuro-endocrine tumors. Indian J Nucl Med 2012 [cited 2013 Apr 11];27:55-8.
2. Harisankar CN, Preethi GR, George M. Hybrid SPECT/CT evaluation of dual ectopia of thyroid in the absence of orthotopic thyroid gland. Clin Nucl Med. 2012 Jun;37(6):602-3.
3. Harisankar CN, Mittal BR, Kashyap R, Bhattacharya A, Singhi S. (18)F-FDG Positron Emission Tomography in Multifocal Pyomyositis. World J Nucl Med. 2012 Jan;11(1):22-3.
4. Kamaleshwaran KK, Mittal BR, Harisankar CB, Bhattacharya A, Singh SK, Mandal AK. Predictive value of serum prostate specific antigen in detecting bone metastasis in prostate cancer patients using bone scintigraphy. Indian J Nucl Med [serial online] 2012 [cited 2013 Jul 5];27:81-4.
5. Sasikumar A, Harisankar CN, Bhattacharya A, Kapoor R, Mittal BR. 18F-FDG PET/CT in a case of malignant priapism secondary to metastasis from mucoid adenocarcinoma of the cecum. Clin Nucl Med. 2013 Feb;38(2):e91-2.
6. Santhosh S, Bhattacharya A, Harisankar CN, Kochhar R, Mittal BR. Role of 18F-FDG PET/CT in the Management of a Case of Autoimmune Pancreatitis With Extrapancreatic Manifestations. Clin Nucl Med. 2013 Mar 18. [Epub ahead of print]
7. Santhosh S, Harisankar CNB, Bhattacharya A, Gupta R, Mittal BR. F-18 FDG PET/CT in the staging of linitis plastica caused by primary gastric adenocarcinoma. In press, World J Nucl Med (accepted for publication)
8. Harisankar CN. Widespread subcutaneous metastases in a patient with breast cancer: Evaluation with fluoro deoxy-glucose positron emission tomography-computed tomography. Indian J Nucl Med. 2013 Jul;28(3):190-1
9. Harisankar CN. Incidentally detected vesico inguinal hernia on fluoro-deoxy glucose positron emission tomography-computed tomography. Indian J Nucl Med. 2013 Apr;28(2):127-8
10. Agrawal K, Bhattacharya A, Singh N, Harisankar CN, Mittal BR. Skeletal muscle metastases as the initial manifestation of an unknown primary lung cancer detected on F-18 fluorodeoxyglucose positron emission tomography/computed tomography. Indian J Nucl Med. 2013 Jan;28(1):34-5
11. Harisankar CN, Preethi GR, Chungath BB. Hybrid SPECT/CT evaluation of Marine-Lenhart syndrome. Clin Nucl Med. 2013 Feb;38(2):e89-90.
12. Harisankar CNB. Recurrent thyrotoxicosis due to hyperfunction of multiple ectopic thyroid tissue and residual thyroid lobes 15 years after thyroidectomy: Evaluation using Techentium scanning and hybrid SPECT/CT. Thyroid research and practice